Bojana Mirosavljević

About Bojana Mirosavljević

Bojana Mirosavljević is a uniquely positioned professional who bridges two critical worlds: the precision of embryology laboratories and the power of patient advocacy.
As a trained embryologist with an MSc in Reproductive Biology – Embryology and chemistry background, she brings extensive hands-on experience in human reproduction, IVF procedures, and preimplantation genetic testing (PGT). 

Simultaneously, as an internationally recognized patient advocacy leader with over 15 years of success advancing rare disease strategies across Europe and globally, she champions the integration of patient voices into clinical development, regulatory frameworks, and research design.

Embryology Expertise:

Bojana’s scientific foundation is built on comprehensive training and practical experience in assisted reproductive technologies.

Her laboratory expertise includes in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), embryo culture, cryopreservation of gametes and embryos, and embryo transfer procedures.

She has specialized in preimplantation genetic testing (PGT), continuously enhancing her knowledge and technical skills through advanced training programs at prestigious international embryology training centers.

Her passion lies in combining scientific excellence with clinical practice to improve IVF outcomes and support couples on their journey to parenthood. This hands-on laboratory experience gives her unique insight into the technical, emotional, and ethical dimensions of assisted reproduction.

Patient Advocacy Leadership:

As Founder and President of the rare disease organization “LIFE” and recipient of the prestigious EURORDIS Black Pearl Award, Bojana has built deep connections within the European and global advocacy community.

She specializes in embedding patient voice into clinical development, regulatory planning, and trial design for global rare disease programs—working closely with EMA (European Medicines Agency), FDA (Food and Drug Administration), and HTA (Health Technology Assessment) bodies.

Her scientific background in chemistry and embryology, combined with certification as a EUPATI (European Patients’ Academy on Therapeutic Innovation) Patient Expert, allows her to pair technical expertise with patient-centered strategy.

She serves on multiple EU advisory boards, leading initiatives that improve trial feasibility, accelerate patient access to treatments, and elevate patient perspectives in research and development.

The Intersection:

Bojana’s dual expertise creates a powerful synergy. Her understanding of reproductive genetics through PGT work informs her advocacy for precision medicine and gene therapy.

Her patient advocacy experience enriches her approach to embryology, ensuring that couples receive not just technical excellence but compassionate, patient-centered care. She builds trusted, cross-cultural partnerships that bridge laboratory science, clinical practice, regulatory frameworks, and patient needs.

Education & Credentials

• MSc in Reproductive Biology – Embryology
• Degree in Chemistry
• Certified EUPATI Patient Expert – European Patients’ Academy on Therapeutic Innovation
• Advanced Embryology Training – Multiple international training centers specializing in embryology techniques and PGT
• EURORDIS Black Pearl Award – Recognizing exceptional contribution to rare disease advocacy
• 15+ years of experience in patient advocacy and rare disease strategy
• Extensive laboratory experience in IVF, ICSI, embryo culture, cryopreservation, and PGT
• Member – Multiple EU advisory boards for rare disease and patient advocacy

   

Professional Experience & Focus

Founder & President – Rare Disease Organization “LIFE” (Current)

• Lead strategic direction for rare disease patient organization
• Champion patient voice in clinical development and regulatory processes
• Build partnerships with pharmaceutical companies, regulatory bodies, and research institutions
• Advocate for improved access to treatments and precision medicine

   

Embryologist – Specialized in IVF and PGT (Current)

• Perform in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) procedures
• Manage embryo culture, monitoring, and development assessment
• Conduct cryopreservation of gametes and embryos using vitrification and slow-freeze protocols
• Perform embryo transfer procedures and provide technical support to clinical teams
• Specialize in preimplantation genetic testing (PGT) for genetic screening and diagnosis
• Continuously update skills through international advanced training programs

   

Patient Advocacy Strategic Leader – European & Global Rare Disease Programs (15+ years)

• Embed patient voice into clinical trial design, regulatory submissions, and HTA evaluations
• Collaborate with EMA, FDA, and international regulatory bodies on patient-centered drug development
• Lead global initiatives aligning patient needs with regulatory and health technology assessment expectations
• Serve on EU advisory boards shaping rare disease policy and precision medicine access
• Design and execute patient engagement strategies for pharmaceutical R&D programs
• Build cross-cultural partnerships improving trial feasibility and patient recruitment

   

Scientific Advisor & EUPATI Expert (Current)

• Bridge scientific expertise with patient perspective in therapeutic innovation
• Provide expert consultation on gene therapy and precision medicine programs
• Support pharmaceutical companies in integrating patient insights into development pipelines

   

Specialties / Key Interests

• Embryology and assisted reproductive technologies (IVF, ICSI)
• Preimplantation genetic testing (PGT-A, PGT-M, PGT-SR)
• Embryo culture techniques and quality assessment
• Cryopreservation of gametes and embryos
• Embryo transfer procedures
• Patient advocacy and rare disease strategy
• Clinical trial design and patient engagement
• Regulatory affairs (EMA, FDA, HTA bodies)
• Gene therapy and precision medicine
• Patient voice integration in R&D
• Cross-cultural partnership building
• Reproductive genetics and genetic counseling
• Patient-centered care in fertility treatment
• Scientific communication and education

   

Approach / Philosophy

Bojana believes that the best outcomes in reproductive medicine and healthcare arise when scientific excellence meets genuine patient understanding. Her philosophy is built on three interconnected pillars:

Scientific Rigor with Human Touch: Whether in the embryology laboratory or in advocacy boardrooms, Bojana maintains the highest scientific standards while never losing sight of the human lives behind every procedure, trial, or policy decision.

Patient Voice as Essential, Not Optional: Her experience on both sides, as a scientist and as a patient advocate, has convinced her that patient perspectives must be embedded at every stage of clinical development, from trial design to regulatory approval to treatment access. Patients are not just recipients of care; they are partners in advancing medicine.

Bridging Worlds: Bojana excels at translation—helping scientists understand patient needs, helping patients understand complex science, and helping regulatory bodies appreciate both perspectives. Her unique dual expertise allows her to build trusted partnerships across cultures, disciplines, and stakeholder groups.

For Bojana, embryology is not just about creating embryos—it’s about creating families with compassion and precision. Patient advocacy is not just about speaking up—it’s about fundamentally changing how medicine is developed and delivered. By combining both worlds, she works to ensure that every couple receives care that is both technically excellent and deeply human.

How She Can Help Our Members

Within Family By Choice, Bojana provides dual expertise that is rare in the fertility field. Her embryology background offers members technical insight into IVF laboratory procedures, PGT options, and embryo quality assessment, helping them understand the science behind their treatment.

Her patient advocacy experience ensures that members’ voices, concerns, and needs are heard and integrated into educational content and support strategies. She brings a unique perspective on genetic testing in reproduction, precision medicine approaches, and patient-centered care that empowers members to make informed decisions while feeling genuinely supported throughout their fertility journey.

Community Impact

• Founder & President of rare disease organization “LIFE”, advancing patient advocacy across Europe
• EURORDIS Black Pearl Award recipient, recognizing exceptional contribution to rare disease community
• Certified EUPATI Patient Expert, bridging patient perspective with therapeutic innovation
• Member of multiple EU advisory boards, shaping rare disease policy and patient access to treatments
• 15+ years leading global patient advocacy initiatives aligned with EMA, FDA, and HTA frameworks
• Pioneer in patient voice integration into clinical trial design and regulatory planning
• Advocate for gene therapy and precision medicine, particularly in reproductive genetics context
• International embryology educator, training and advancing IVF laboratory standards
• Specialist in preimplantation genetic testing (PGT), helping couples make informed genetic decisions
• Cross-cultural partnership builder, improving trial feasibility and accelerating patient access to innovative treatments
• Champion of patient-centered care in both fertility treatment and rare disease management
• Bridge between laboratory science and patient experience, ensuring technical excellence serves human needs